258 related articles for article (PubMed ID: 17133606)
21. Crystal structure of the urokinase receptor in a ligand-free form.
Xu X; Gårdsvoll H; Yuan C; Lin L; Ploug M; Huang M
J Mol Biol; 2012 Mar; 416(5):629-41. PubMed ID: 22285761
[TBL] [Abstract][Full Text] [Related]
22. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
[TBL] [Abstract][Full Text] [Related]
23. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
[TBL] [Abstract][Full Text] [Related]
24. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
25.
Napolitano F; Rossi FW; Pesapane A; Varricchio S; Ilardi G; Mascolo M; Staibano S; Lavecchia A; Ragno P; Selleri C; Marone G; Matucci-Cerinic M; de Paulis A; Montuori N
Front Immunol; 2018; 9():574. PubMed ID: 29670612
[TBL] [Abstract][Full Text] [Related]
26. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
[TBL] [Abstract][Full Text] [Related]
27. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.
Bass R; Werner F; Odintsova E; Sugiura T; Berditchevski F; Ellis V
J Biol Chem; 2005 Apr; 280(15):14811-8. PubMed ID: 15677461
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins.
Chavakis T; May AE; Preissner KT; Kanse SM
Blood; 1999 May; 93(9):2976-83. PubMed ID: 10216093
[TBL] [Abstract][Full Text] [Related]
29. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
Mazzieri R; D'Alessio S; Kenmoe RK; Ossowski L; Blasi F
Mol Biol Cell; 2006 Jan; 17(1):367-78. PubMed ID: 16267271
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.
Beloglazova I; Stepanova V; Zubkova E; Dergilev K; Koptelova N; Tyurin-Kuzmin PA; Dyikanov D; Plekhanova O; Cines DB; Mazar AP; Parfyonova Y
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119157. PubMed ID: 34619163
[TBL] [Abstract][Full Text] [Related]
31. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
33. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
34. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A
J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
[TBL] [Abstract][Full Text] [Related]
36. Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor.
Chintala SK; Mohanam S; Go Y; Venkaiah B; Sawaya R; Gokaslan ZL; Rao JS
Mol Carcinog; 1997 Dec; 20(4):355-65. PubMed ID: 9433480
[TBL] [Abstract][Full Text] [Related]
37. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
[TBL] [Abstract][Full Text] [Related]
39. Regulation of integrin function by the urokinase receptor.
Wei Y; Lukashev M; Simon DI; Bodary SC; Rosenberg S; Doyle MV; Chapman HA
Science; 1996 Sep; 273(5281):1551-5. PubMed ID: 8703217
[TBL] [Abstract][Full Text] [Related]
40. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
